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Abstract: The lower female reproductive tract (FRT) is comprised of the cervix and vagina,
surfaces that are continuously exposed to a variety of commensal and pathogenic organisms.
Sexually transmitted viruses, such as herpes simplex virus type 2 (HSV-2), have to traverse the
mucosal epithelial lining of the FRT to establish infection. The majority of current culture systems
that model the host-pathogen interactions in the mucosal epithelium have limitations in simulating
physiological conditions as they employ a liquid-liquid interface (LLI), in which both apical and
basolateral surfaces are submerged in growth medium. We designed the current study to simulate
in vivo conditions by growing an immortalized vaginal epithelial cell line (Vk2/E6E7) in culture
with an air-liquid interface (ALI) and examined the effects of female sex hormones on their growth,
differentiation, and susceptibility to HSV-2 under these conditions, in comparison to LLI cultures.
ALI conditions induced Vk2/E6E7 cells to grow into multi-layered cultures compared to the
monolayers present in LLI conditions. Vk2 cells in ALI showed higher production of cytokeratin
in the presence of estradiol (E2), compared to cells grown in progesterone (P4). Cells grown under
ALI conditions were exposed to HSV-2-green fluorescent protein (GFP) and the highest infection
and replication was observed in the presence of P4. Altogether, this study suggests that ALI
cultures more closely simulate the in vivo conditions of the FRT compared to the conventional
LLI cultures. Furthermore, under these conditions P4 was found to confer higher susceptibility to
HSV-2 infection in vaginal cells. The vaginal ALI culture system offers a better alternative to study
host-pathogen interactions.
Keywords: herpes simplex virus type 2; HSV-2; female genital tract; vaginal cells; air-liquid interface;
female sex hormones; estradiol; progesterone; medroxyprogesterone acetate; Vk2/E6E7 cells
1. Introduction
Approximately 417 million people (range: 274–678 million) worldwide are seropositive for herpes
simplex virus type 2 (HSV-2) with an incidence of 19.2 million [1]. HSV-2 infection is widely prevalent
around the world and lacks a definitive cure, making it a critical global concern. More females
(267 million) are infected with HSV-2 than males (150 million), and data indicates that seroprevalence
is higher in women (25.6%) compared to men (17.8%) in the USA [1,2]. While some studies have linked
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the higher infection rates in females to the greater surface area of the female reproductive tract (FRT)
compared to the male reproductive tract, other studies suggest that other biological factors such as
presence of female sex hormones contribute to the difference in infectivity and seroprevalence [3–7].
Transmission of HSV-2 in women occurs predominantly in the FRT through the direct infection of
genital epithelium [8]. Epithelial cells of the FRT mucosa are the primary barriers against other sexually
transmitted viruses, such as human immunodeficiency virus (HIV) and pathogenic bacteria [9–11].
Vaginal mucosal lining, which is made of stratified squamous epithelium, plays a critical role in
reducing the risk of pathogenic invasion in the lower FRT and contributes to the maintenance of
vaginal tissue homeostasis [12–15]. Despite these recognized functions, much remains to be learned
about their interactions with commensal and pathogenic organisms in the FRT. Thus, an in vitro model
that closely simulates the in vivo environment of the lower FRT is crucial to elucidate the complex
interactions between sexually transmitted pathogens and host cells.
In order to simulate the interactions in the lower FRT more closely, it is vital that we understand
its unique physiology. The in vivo environment of the FRT is mainly regulated by female sex
hormones like estradiol (E2) and progesterone (P4) [4,16,17]. The immune system of the FRT has
evolved to balance the processes of procreation and immune protection through the regulation of E2
and P4, two hormones that are produced cyclically by the ovaries during the menstrual cycle [15,16].
Many studies have elucidated that sex hormones can modify antiviral immune function and alter
susceptibility to sexually transmitted viruses [5,18–21]. E2 is considered to be generally protective
against sexually transmitted viral infections, while P4 and progestin-based hormonal contraceptives
have been shown to increase susceptibility [5,18–23]. Studies have demonstrated that the presence
of E2 can enhance CD4+ T cell antiviral immunity in the female FRT [24] and also offer greater
protection against HSV-2 specific pathologies [5,21], while P4 leads to excessive genital inflammation
and can reverse the effects of E2 in vivo [19]. It is also important to consider the effects of hormonal
contraceptives in sexually transmitted virus acquisition. Medroxyprogesterone acetate (MPA), a first
generation synthetic progestin used by over 100 million women worldwide, has been shown to play
a role in enhancing HSV-2 infection in rodent and non-human primate studies [23,25]. MPA also
enhances HIV uptake and transcytosis of HIV in primary genital epithelial cells [26].
Significant efforts have been invested in understanding and modeling the complex environment of
the lower FRT. Earlier culture models employed the conventional liquid-liquid interface (LLI) approach
by providing a growth medium to both apical and basolateral sides of cultures [27–32]. However,
the vaginal epithelium in vivo draws nutrients only from its basolateral side, and is in contact with air
and a limited volume of mucus and secretion, forming a strong physical and biochemical barrier on its
apical side against the vast variety of commensal and pathogenic organisms [16,33]. More recently,
attempts have been made to better simulate the complex mucosal epithelial environment in vivo.
Hjelm et al. have developed a three-dimensional organotypic human vaginal epithelial cell model,
which has been shown to exhibit physiologically relevant features such as the stratified squamous
epithelium with microvilli, tight junctions, microfolds, and mucus [34]. This model was applied
for screening microbicide compounds for safety and efficacy; however, it has not been utilized to
study host-pathogen interactions. To characterize aspects of the multilayered growth and polarity
of the uterine cervical epithelium, studies have cultured human and porcine ectocervical epithelium
in air-liquid interface (ALI) [35–37]. The ALI conditions were achieved by exposing the apical side
of vaginal epithelial cells to air supplemented with 5% CO2 and the basolateral side to the growth
medium, mimicking studies conducted in tracheal and bronchial epithelia to understand the complex
functions of the human airway [38–40]. However, no studies have focused on vaginotropic viruses
such as HSV-2.
We designed the current study to determine if vaginal cells grown under ALI culture conditions
would have distinct morphology and functions compared to LLI conditions. We used the Vk2/E6E7
(Vk2) cell line that was developed by immortalizing normal vaginal cells with a defective retroviral
construct expressing human papilloma virus (HPV) type 16 E6 and E7 (LXSN-16/E6E7) [41]. HPV E6
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and E7 viral oncogenes increase epithelial cell proliferation but do not lead to complete transformation
of the cell line. These cells were non-tumorigenic and maintained a stable epithelial phenotype similar
to the cells they were derived from [41]. Primary vaginal tissue is difficult to obtain and even more
difficult to culture because the majority of the cells are terminally differentiated. Many studies use
HeLa and HEC-1 cells, which are transformed cells and their similarity to primary cells is debatable.
Since the advent of the HPV immortalized cell lines, they have become the mainstay for researchers
examining host-pathogen interactions [41–47]. The Vk2 cell line has been extensively characterized and
used in a wide variety of studies, ranging from basic studies examining innate responses to bacterial
and viral pathogens to pre-clinical assessment of genital epithelium response to microbicides [27,47–50].
Vk2 cells have been shown to also express a variety of steroid hormone receptors and respond to
estradiol, progesterone, and glucocorticoids [29]. Therefore, these Vk2 cells are a suitable model to
examine hormone effects.
Our goal in the current study was to determine the differences in Vk2 cell growth, morphology,
cytokeratin expression, and HSV-2 susceptibility between ALI and the conventional LLI. Furthermore,
to accurately simulate the in vivo environment of the lower FRT, we examined the effects of female sex
hormones and MPA on the vaginal cell functions.
2. Materials and Methods
2.1. Generating Air-Liquid Interface (ALI) and Liquid-Liquid Interface (LLI) Cultures of Vk2 Cell Line
To generate the Vk2/E6E7 (Vk2) culture, 60,000 cells were seeded on 0.4 µm pore-sized transwell
polystyrene inserts (BD Falcon, Mississauga, ON, Canada), and keratinocyte serum-free medium
(Life Technologies, Carlsbad, CA, USA) supplemented with 0.1 ng/mL human recombinant epidermal
growth factor (Life Technologies), 0.05 mg/mL of bovine pituitary extract (Life Technologies), CaCl2,
and 100 units/mL penicillin/streptomycin (Sigma Aldrich, Oakville, ON, Canada) were added to the
apical and basolateral sides of the culture, as described in [41]. LLI culture was generated by keeping
the media on both the apical (300 µL) and basolateral sides (500 µL) (Figure 1A). For ALI culture,
media from the apical side was removed after 24 h of seeding the cells and media was only present in
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Figure 1. Culture design comparison. (A) liquid-liquid interface (LLI); (B) air-liquid interface (ALI).
2.2. Hematoxylin and Eosin and Actin Staining of ALI and LLI Cultures
After three and 10 days of culture, Vk2 cells were fixed in 4% paraformaldehyde for 24 h
and washed in phosphate-buffered saline (PBS; McMaster Immunology Research Centre Media
Production Facility, Hamilton, ON, Canada). Cultures were then excised from transwell polystyrene
inserts, stored in 70% ethanol, processed for histology and embedded in paraffin wax. Sections of
4–6 micron were cut and stained with hematoxylin and eosin (H&E) at the McMaster Immunology
Research Centre Histology lab (Hamilton, ON, Canada). All samples were imaged on a Leica HC
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DMR microscope under 40× objective (Leica Microsystems, Wetzlar, Germany). To visualize the
filamentous F-actin, after three and 10 days of culture, Vk2 cells were fixed in 4% paraformaldehyde,
permeabilized with 0.1% Triton X-100 (Mallinckrodt Inc., Paris, KY, USA), and blocked for 30 min in
blocking solution (5% bovine serum albumin and 5% goat serum (Sigma-Aldrich) in 0.1% Triton X-100
(Mallinckrodt Inc.)). Cultures were incubated with Texas Red-conjugated phalloidin (Sigma Aldrich)
for 1 h at 37 ◦C. Cultures were then washed three times with PBS, and the polystyrene inserts were
excised and mounted onto glass slides. Samples were imaged using an inverted laser-scanning confocal
microscope at the McMaster Electron Microscopy Facility at 40× objective (LSM 510, Carl Zeiss
Canada Ltd., Toronto, ON, Canada).
2.3. Pancytokeratin Staining of ALI and LLI Cultures Exposed to Female Sex Hormones and MPA
Estradiol (E2, Sigma Aldrich) (10−9 M), progesterone (P4, Sigma Aldrich) (10−7 M),
or medroxyprogesterone acetate (MPA, Pfizer, Montreal, QC, Canada) (10−9 M) were added
to the keratinocyte serum-free medium (Life Technologies) and Vk2 cells were grown in
hormone-supplemented medium in the same volume as described above. Cells grown in medium
containing different female sex hormones E2, P4, or MPA were cultured for 10 days, and fixed with 4%
paraformaldehyde, washed with PBS, permeabilized with 0.1% Triton X-100 (Mallinckrodt Inc.),
and blocked for 30 min in a blocking solution (5% bovine serum albumin and 5% goat serum
(Sigma Aldrich) in 0.1% Triton X-100). To visualize human cytokeratin 10, 13, 18, and 19 that are
present in Vk2 cells, monoclonal anti-cytokeratin pan antibody (Sigma Aldrich) was diluted to 1:200
in blocking solution and incubated with cultures for 1 h at 37 ◦C. Then, the cultures were washed
with PBS and incubated with the secondary antibody, Alexa Fluor 488-conjugated goat anti-mouse
IgG (1.5 µg/µL; Molecular Probes, Eugene, OR, USA), for 1 h at room temperature. Cell nuclei were
stained with propidium iodide (500 nM; Molecular Probes). Cultures were then washed three times
with PBS, and the polystyrene inserts were excised and mounted onto glass slides. Samples were
imaged using an inverted laser-scanning confocal microscope at the McMaster Electron Microscopy
Facility at 20× objective (LSM 510, Carl Zeiss Canada Ltd., Toronto, ON, Canada).
2.4. Cell Viability Assay
Vk2 cell viability under different hormonal conditions was assessed by trypan blue exclusion
assay [51]. Vk2 cells exposed to no hormone (NH), E2, P4, or MPA were detached from the transwell
inserts by gently scraping the cells with the pipette tip and were pelleted down, and re-suspended
in 10% fetal bovine serum (FBS) Dulbecco’s modified Eagle’s medium (DMEM). Resuspended Vk2
cells were exposed to trypan blue dye (Life Technologies Inc.) in a 1:1 ratio of cell suspension to dye.
Cells were loaded onto a hemocytometer and counted under a light microscope. Cell viability was
assessed by subtracting the number of dead cells, stained in blue, from the total number of cells and
was calculated in terms of percent of live cells.
2.5. HSV-2 Infection in LLI and ALI Culture Exposed to Female Sex Hormones and MPA
After 10 days of culture in medium containing different female sex hormones, Vk2 cells were
infected apically with 104 plaque-forming units (PFU) of wild-type HSV-2 or thymidine kinase (TK)−
HSV-2-green fluorescent protein (GFP) in 100 µL of respective keratinocyte serum-free hormone
containing media (NH, E2, P4, or MPA). The cells were infected with HSV-2 for 2 h at 37 ◦C as
previously described [52]. Briefly, after 2 h the inoculum was removed, cells were washed and the
respective hormone media was added to both the apical (300 µL) and basolateral (500 µL) sides.
The cells were incubated at 37 ◦C for 24 h and the supernatants were collected from the apical and
basolateral sides and titered by plaque assay on Vero cells, as described before to measure viral
shedding [19]. Briefly, Vero cells were grown to 80% confluence in 24-well plates. Samples were diluted
(10−2 to 10−7) and added to monolayers. Infected monolayers were incubated at 37 ◦C for 2 h for
viral adsorption. After 2 h, viral supernatants were removed and wells were replenished with media
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without any virus. Infection was allowed to occur for 48 h at 37 ◦C. Monolayers were then fixed and
stained with crystal violet, and viral plaques were counted under a light microscope. PFU per milliliter
was calculated by taking a plaque count for every sample and taking into account the dilution factor.
For HSV-2-GFP infected cells, cultures were washed with PBS five times and the cell nuclei were
stained with propidium iodide (500 nM; Molecular Probes). Cultures were then washed three times
with PBS, excised from polystyrene inserts, and mounted onto glass slides. Samples were imaged
using an EVOS™ FL digital inverted fluorescence microscope (Thermo Fisher Scientific, Burlington,
ON, Canada) under a 20× objective.
2.6. Statistical Analysis
GraphPad Prism Version 5 (GraphPad Software, San Diego, CA, USA) was used to compare
three or more means by one-way analysis of variance (ANOVA). When an overall statistically significant
difference was seen, post-tests were performed to compare pairs of treatments, and the Bonferroni’s
multiple comparison method was used to adjust the p-value. An alpha value of 0.05 was set for
statistical significance. p-values for each analysis are indicated in the figure legends.
3. Results
3.1. Vk2 Cells Grow into Multi-Layered Cultures in ALI Conditions
To determine whether the ALI conditions lead to epithelial cell cultures that physiologically
simulate in vivo vaginal cells compared to the LLI conditions, we first examined the cell growth and
morphology in these cultures through H&E staining and F-actin staining. Confluent Vk2 cells were
fixed and stained after three and 10 days of culture. Vk2 cells in LLI culture grew as monolayers of
simple squamous epithelium, while the cells in ALI culture grew and differentiated into multilayered,
stratified squamous epithelium, which is analogous to the vaginal morphology in vivo (Figure 2).
These results provided evidence that ALI culture conditions resemble more closely the vaginal cells
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Figure 2. Hematoxylin and eosin (H&E) staining (A) and filamentous F-actin staining (B) comparison
between the LLI and the ALI interface of Vk2 cells after 10 days of culture. Vk2 cells in ALI culture grew
into multilayered epithelium compared to the monolayers seen in LLI. All samples were imaged on
Leica HC DMR microscope under a 40× objective (Leica Microsystems). A minimum of three replicates
per experimental condition was included. Representative images are shown.
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3.2. Estradiol Increases Cytokeratin Expression
Since we observed a clear difference in stratification patterns between ALI and LLI cultures,
we next measured the ability of cells to express cytokeratin, an epithelial cell specific protein, to study
the differentiation of Vk2 cells under these distinct conditions. Since vaginal cells and their functions,
including growth and differentiation, are profoundly affected by female sex hormones, we decided
to compare cytokeratin expression in the presence of E2, P4, or MPA. The hormone concentrations
used for these studies were based on the serum concentrations of E2 and P4 seen under physiological
conditions (menstrual cycle E2: 10−11 M to 10−10 M and P4: 10−9 M to 10−8 M; pregnancy E2: 10−9 M
and P4: 10−6 M) and serum levels of Depot medroxyprogesterone acetate (DMPA) observed following
subcutaneous injection (1 ng/mL) and have been described before [26]. Exposing Vk2 cells to different
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Figure 3. Cytokeratin staining comparison between the LLI and ALI of Vk2 cells after treatment with
female sex hormones and medroxyprogesterone acetate (MPA). (A) Vk2 cells grown to confluence
for 10 days were expos d to n hormo ( H), estradiol (E2; 10−9 M), progesterone (P4; 10−7 M),
and medroxyprogesterone acetate (MPA; 10−9 M). Cell viability was measured using the trypan blue
assay and expressed as percent of live cells in culture; (B) Pancytokeratin staining, green fluorescence,
was done using mouse nti-hum n monoclonal anti-pan cytok ratin antibody. Propidium iodide was
used for nuclear counter-staining, red fluorescence. All samples were imaged on an inverted confocal
laser-scanning microscope. Representative images are shown. Images were taken in the X, Y plane;
(C) Relative fluorescence of cytokeratin (green) to nuclear stain (red) was measured to quantify the
amount of cytokeratin present per cell. Data shown represent mean ± standard error of the mean
(SEM) of three separate cultures. * p < 0.05. Three replicates per experimental condition were included
for each experiment. Magnification 20×.
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Cytokeratins are proteins expressed in the cytoplasm of epithelial cells as part of a complex
network that forms the cytoskeleton and extends from the surface of the nucleus to the
cell membrane [53,54]. Additionally, they interact with desmosomes and hemidesmosomes,
thereby assisting in cell-to-cell adhesion and barrier function [53–55]. Vk2 cells are known to express
human cytokeratin 10, 13, 18, and 19 [41]. In addition, estradiol is known to upregulate vaginal
epithelium proliferation and cytokeratin expression, as well as many other proteins found in epithelial
cells [56–60]. The vaginal epithelium in women undergoes subtle yet statistically significant thickening
during the menstrual cycle, unlike the very clear thickening seen in rodent species at estrus [59].
In order to determine if hormone treatments had an effect on cytokeratin expression under ALI
and LLI conditions, Vk2 cells grown under different conditions were stained using a pan-cytokeratin
antibody. Both ALI and LLI cultures appeared to show higher expression of cytokeratin proteins in E2
treated cells (Figure 3B, green fluorescence). Relative fluorescence of the images was measured using
the ImageJ software and their ratio was calculated for each field. When the fluorescence was normalized
to the nuclear staining, a significant difference in cytokeratin expression was observed between E2 and
P4 treatment under ALI conditions (Figure 3C), possibly due to the increased proliferation of cells in
E2 cultures. These results indicate that the effect of hormones on cytokeratin expression in vaginal
cells was more pronounced under ALI conditions.
3.3. HSV-2/GFP Infection in Vk2 Cells Cultured in Progesterone Is Higher Than in Estradiol
Since the effect of hormones on epithelial cell differentiation appeared to be enhanced in ALI
conditions, we next examined the effects of female sex hormones on susceptibility to HSV-2 infection.
We infected Vk2 cells grown in ALI and LLI conditions with a GFP-labelled thymidine kinase
HSV-2 virus (HSV-2-GFP) and used fluorescence microscopy to visualize the infection. The relative
fluorescence of the HSV-2-GFP (green) and the nuclear stain (red) was measured using the ImageJ
software and their ratio was calculated in each field, in order to estimate the viral infection per cell.
Under ALI conditions, Vk2 cells grown and exposed to HSV-2-GFP in the presence of P4 showed
a significantly higher infection per cell compared to the E2 group (Figure 4A). A similar trend of higher
relative fluorescence was seen in the P4 group in LLI cultures as well, but did not reach statistical
significance. Overall, the highest infections were visualized in fluorescence microscopy images of
the P4 conditions in both ALI and LLI (Figure 4B). These results indicate that P4 may play a role in










significanc . Overall, t e highest infecti s were visualized in fluorescence microscopy images of the 






Nuclei  were  counter‐stained  with  propidium  iodide.  (A)  Images  were  taken  to  compare  green 
fluorescence  visually;  (B) Relative  fluorescence  of HSV‐2/GFP  (green)  to  nuclear  stain  (red) was 
measured to quantify the amount of HSV‐2 infection per cell. Data shown represented mean ± SEM 
of  three separate cultures. ** p < 0.01. All samples were  imaged on an EVOS™ FL digital  inverted 
fluorescence microscope with a 20× objective.  Images presented are  representative of one of  three 
images acquired from the experiments. 
Figure 4. Cont.

















Nuclei  were  counter‐stained  with  propidium  iodide.  (A)  Images  were  taken  to  compare  green 
fluorescence  visually;  (B) Relative  fluorescence  of HSV‐2/GFP  (green)  to  nuclear  stain  (red) was 
measured to quantify the amount of HSV‐2 infection per cell. Data shown represented mean ± SEM 
of  three separate cultures. ** p < 0.01. All samples were  imaged on an EVOS™ FL digital  inverted 
fluorescence microscope with a 20× objective.  Images presented are  representative of one of  three 
images acquired from the experiments. 
Figure 4. Effect of female sex hormones and MPA on HSV-2-GFP infection in Vk2 cells grown in
ALI and LLI. Vk2 cells grown for 10 days to co fluence in the prese ce r absen of female sex
hormones were exposed to HSV-2-GFP at 104 plaque-forming units (PFU) for two hours in both ALI
and LLI. Nuclei were counter-stained with propidium iodide. (A) Images were taken to compare
green fluorescence visually; (B) Relative fluorescence of HSV-2/GFP (green) to nuclear stain (red) was
measured to quantify the amount of HSV-2 infection per cell. Data shown represented mean ± SEM
of three separate cultures. ** p < 0.01. All samples were imaged on an EVOS™ FL digital in erted
fluorescence micros op w th a 20× objective. Images present d are rep senta ive of one ee
images acquired from the experiments.
3.4. Progesterone Increases Viral Replication in Vk2 Cells in Both ALI and LLI Cultures
To confirm the effect of P4 on the enhancement of HSV-2 infection, we measured the amount of
virus shed by the Vk2 cells in ALI or LLI cultures, an indicator of virus replication, following each
sex hormone treatment. Confluent Vk2 cultures exposed to sex hormones in ALI or LLI conditions
were infected with wild-type HSV-2, and at 24 h post-infection, apical and basolateral cell culture
supernatants were collected to measure viral shedding. Overall, Vk2 cells in the ALI culture showed
higher viral shedding than in the LLI culture (Figure 5). In LLI, cells exposed to P4 and MPA
showed significantly higher viral shedding than when exposed to E2 and the no hormone control
(Figure 5A), while in ALI, P4 group showed significantly higher viral titers than all other treatment
groups (p < 0.0001) (Figure 5B). Thus, the trend of the P4 group under ALI conditions displaying the
highest infectivity and the E2 group displaying the lowest was consistent with the HSV-2-GFP infection
results in ALI (Figure 4B). Overall there was consistency between the ALI and LLI cultures in that both
showed significant increase in HSV-2 shedding in the P4 group compared to the control (no hormone)
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Figure 5. Difference  in HSV‐2 virus shedding by Vk2 cells  in ALI and LLI conditions, exposed  to 
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Figure 5. Difference in HSV-2 virus shedding by Vk2 cells in ALI and LLI conditions, exposed to
different female sex hormones and MPA. To measure the viral shedding in Vk2 cell supernatants,
Vk2 cells were exposed to 104 PFU of wild-type HSV-2 for 2 h in both LLI (A) and ALI (B).
Apical supernatants were collected and shed virus was measured by plaque assay on Vero cells
(PFU/mL). Data were pooled from three separate experiments and are shown as mean± SEM. * p < 0.05,
** p < 0.01, **** p < 0.0001.
4. Discussion
To the best of our knowledge, this is the first study that compared air-liquid interface to
liquid-liquid interface cultures in order to examine under which conditions the vaginal Vk2 cells
simulate in vivo growth and functions. Furthermore, we examined the effects of female sex hormones
in Vk2 cell lines in terms of growth, differentiation, as well as HSV-2 infection under both ALI
and LLI conditions. We demonstrated that ALI conditions support the development of stratified
squamous Vk2 cell layers, which simulates the in vivo vaginal physiology more closely than LLI
and therefore may be a better model to study host-pathogen interactions in the lower FRT. Vk2 cells
showed a difference in susceptibility to HSV-2 under different hormonal conditions, particularly in
ALI conditions. The presence of female sex hormones and MPA further enhanced the physiological
relevance of the infection model as circulating hormones can alter the immune responses of the vaginal
cells against the virus [17–24]. Based on these results, we conclude that ALI conditions represent more
closely the FRT microenvironment and therefore may be a better model to study interactions between
pathogens and the lower genital tract [15,16].
A significant change in susceptibility was noted between Vk2 cells treated with P4 compared to E2,
especially in ALI cultures. The changes in susceptibility to HSV-2 under these conditions have never
been reported. Our results demonstrate that P4 led to an increased HSV-2 infection and replication
in Vk2 cells grown in ALI and LLI. While viral shedding was higher in both P4 and MPA under
LLI conditions, P4 showed significantly higher viral replication in ALI cultures. This is consistent
with many clinical and experimental studies showing that P4 can lead to increased susceptibility to
sexually-transmitted infections (STI) like HSV-2, Candida albicans, and HIV-1 [19,58,61]. Marx et al.
used subcutaneous hormonal implants in rhesus macaques and showed that P4 made the monkeys
more susceptible to simian immunodeficiency virus type 1 (SIV-1) infection, while E2 demonstrated
protective effects [62]. Therefore, the results from these studies, including our own, suggest that P4
levels can play a significant role in altering the female’s susceptibility to STIs. Although the mechanism
of enhanced viral replication in P4-treated cultures is not clear, ALI conditions could trigger changes
such as enhanced HSV-2 receptor expression or downregulation of certain antiviral innate responses.
Further studies to better characterize the effects of E2 and P4 on susceptibility and innate responses to
HSV-2 are warranted.
In vivo the vaginal squamous epithelium undergoes stratification naturally, such that the top
layers are easily sloughed off and are continuously replaced by the underlying layers. While the
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superficial layers of vaginal epithelium undergo keratinization in some species, including mice,
the human vaginal epithelium is not keratinized [59]. It does however show “cornification”, a process
where the top layers are terminally differentiated and form the “stratum corneum” of the vaginal
epithelium [12]. While the ALI cultures do show multiple layers, we have not extensively examined
whether they became cornified. Future work may examine if such a conversion occurs in the top layers.
The use of ALI cultures in understanding the cellular responses between the host and the
various commensal and pathogenic organisms in the female reproductive tract has great potential.
Although our study only examined the interaction between the Vk2 cells and HSV-2, ALI conditions
could be employed to culture other cell lines from the FRT such as ectocervical (ECT1/E6E7) and
endocervical (END-1/E6E7) cell lines [41–43,46,55]. Additionally, ALI could be used to investigate the
interactions between the host cells and other sexually transmitted pathogens such as hepatitis viruses,
HIV-1, and Chlamydia trachomatis.
We believe that the ALI culture can be further improved to increase its physiological relevance.
Vaginal bacterial communities, which are composed of over 265 microbial species, are thought to
play an important role in preventing colonization by pathogenic organisms in the lower FRT [7,55,63].
Bacteria like Lactobacillus are known to contribute maintaining a healthy vagina and restricting the
growth of foreign organisms by producing bacteriocins and lactic acid, as well as by acidifying the
vaginal environment [63]. The addition of bacteria commonly found in the vaginal tract and of
different female sex hormones to the ALI culture, could be used to further examine the Vk2 cell’s
immune responses against STIs [43]. We limited our study to examining individual effects of E2 and
P4, however, when present together, their interactions can be highly complex. Indeed, E2 and P4
coexist in vivo and their relative levels fluctuate throughout the reproductive cycle [4,15]. Hence,
studies testing the susceptibility of Vk2 cells to HSV-2 in the presence of both E2 and P4 in varying
concentrations are needed to examine their potential synergistic or antagonistic effects.
5. Conclusions
Overall, ALI cultures of Vk2 cells can be used in a broad range of reproductive immunology
studies to understand how vaginal epithelial cells react in presence of viruses or other microbes
in controlled and physiological conditions close to the FRT. Furthermore, our study provides
an understanding that different hormonal conditions in the FRT can contribute to alter susceptibility
towards STIs like HSV-2. Therefore, hormonal microenvironments should be carefully monitored when
using P4-based contraceptives or other hormonal therapies to prevent a risk of higher susceptibility
to STIs.
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